The cluster of C-suite sales immediately after a material agreement and concurrent with an offering suggests insiders are monetizing ahead of potential dilution. Monitor the offering's final size and pricing; if it exceeds $50M, the selling pattern becomes more concerning. The stock has rallied on Phase 2 data but insiders are taking profits — consider hedging exposure.
Price Chart
Executive Summary
Four Avalo Therapeutics insiders — including the CFO, CLO, and CMO — sold a total of $1.53M in open-market stock within days of a $2.25M milestone buyout agreement and an undisclosed public offering. The cluster represents 0.27% of market cap, a modest but notable amount, and the timing immediately after a material agreement and concurrent with an offering raises informed-selling concerns.
Key Financial Metrics
Key Facts
- CFO Christopher Sullivan sold 18,606 shares for $449K on May 7, one day after exercising derivatives at $9.88.
- CLO Paul Varki sold 37,375 shares for $707K on May 6, exercising options at $13.43 and $0.
- CMO Mittie Doyle sold 27,538 shares for $496K on May 6, exercising options at $12.65.
- Director Mitchell Chan sold 3,167 shares for $72K on May 6.
- Total open-market sales: $1.53M, or 0.27% of AVTX's $576M market cap.
- The insider cluster follows a $2.25M milestone buyout option agreement (8-K filed Apr 28) and a public offering prospectus (424B5 filed May 5).
- All four insiders exercised derivative securities at prices well below the market price, then sold shares at the higher market price.
Financial Impact
Insiders sold $1.53M in stock, representing 0.27% of market cap. The offering size is undisclosed but likely dilutive.
Risk Factors
- Undisclosed offering size could be highly dilutive if large relative to current float.
- Insider selling by three top executives (CFO, CLO, CMO) in a tight window signals lack of confidence at current valuation.
- Historical calibration shows AVTX reports have underperformed at T+20, with a -12.64% average return and 0% win rate.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-AVTX-1778529952999 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 19, 2026 6w ago | Insider Cluster | $20.75 $16.69 | ▼ −19.57% | ▼ −17.61% | $14.99 (−27.76%) |
Aug 17, 2026 6w ago | Institutional Cluster | $19.95 $16.07 | ▼ −19.45% | ▼ −17.47% | $14.99 (−24.86%) |
Aug 6, 2026 8w ago | 8-K | $18.70 $19.00 | ▲ +1.60% | ▲ +1.00% | $14.99 (−19.84%) |
Jun 16, 2026 15w ago | 8-K | $14.33 $18.42 | ▲ +28.54% | ▲ +28.34% | $14.99 (+4.61%) |
Jun 16, 2026 15w ago | Press Release | $14.33 $18.42 | ▲ +28.54% | ▲ +28.34% | $14.99 (+4.61%) |
Jun 8, 2026 16w ago | 8-K | $12.90 $19.25 | ▲ +49.22% | ▲ +47.78% | $14.99 (+16.20%) |
May 13, 2026 20w ago | 8-K | $19.85 $13.67 | ▼ −31.13% | ▼ −30.52% | $14.99 (−24.48%) |
May 13, 2026 20w ago | Press Release | $19.85 $13.67 | ▼ −31.13% | ▼ −30.52% | $14.99 (−24.48%) |
May 6, 2026 21w ago | Press Release | $21.81 $13.74 | ▲ +37.00% | ▲ +39.78% | $14.99 (+31.27%) |
May 6, 2026 21w ago | Insider Cluster | $21.81 $13.74 | ▲ +37.00% | ▲ +39.78% | $14.99 (+31.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access